Elena Alvarez-Periel

Elena Alvarez-Periel

Auto-generated profile, based on publicly available information

Elena Alvarez-Periel

Department of Oral Medicine, Penn Dental School, University of Pennsylvania

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NSNuria Suelves
Nuria Suelves
AMAndrés Miguez
Andrés Miguez
SLSaray López-Benito
Saray López-Benito
GBGerardo García-Díaz Barriga
Gerardo García-Díaz Barriga
AGAlbert Giralt
Albert Giralt
VBVerónica Brito
Verónica Brito

29 December 2017 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
EAElena Alvarez-Periel
Elena Alvarez-Periel
MPMar Puigdellívol
Mar Puigdellívol
VBVerónica Brito
Verónica Brito
FPFlorian Plattner
Florian Plattner
JBJames A. Bibb
James A. Bibb
SGSílvia Gines
Sílvia Gines

11 November 2023 in The Journal of Pain
Verified
Journal Article
Closed access
LSLily P. See
Lily P. See
PSPuttipong Sripinun
Puttipong Sripinun
WLWennan Lu
Wennan Lu
JLJiaqi Li
Jiaqi Li
NANaela Alboloushi
Naela Alboloushi
Claire H. MitchellClaire H. Mitchell
Claire H. Mitchell

30 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SGShivesh Ghura
Shivesh Ghura
EAElena Alvarez-Periel
Elena Alvarez-Periel
SNSarah E. Bond Newton
Sarah E. Bond Newton
CACagla Akay-Espinoza
Cagla Akay-Espinoza
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
Subtle variations in the activity and signaling of PERK, an endoplasmic reticulum kinase, can shift stress response outcomes. PERK has three commonly occurring exonic single-nucleotide variants frequently inherited together as part of the PERK haplotype B (PERK-B), which occurs in 28% of the global population and is associated with several chronic neurodegenerative diseases, although its impact on PERK activity remains controversial. We hypothesized that PERK-B was associated with increased activity, altering stress response and stress tolerance, and that minorly but consistently elevated PERK activity, in combination with additional environmental or genetic risk factors, would lead to adverse outcomes. Comparison of stress response between PERK-A, the major PERK haplotype, and PERK-B in neuronal cultures using novel knock-in PERK-B mice alongside wild-type PERK-A mice revealed differential, transient changes. Following ER stress, astrocyte-containing neuronal cultures, but not neuron-only cultures expressing PERK-B exhibited similar levels of eIF2α phosphorylation, the canonical PERK substrate at PERK peak activation point (2h), but showed higher levels at 4–6 h, consistent with altered kinetics of PERK signaling. PERK-B neuronal cultures pretreated with a low-dose PERK-specific activator exhibited increased vulnerability to N-methyl-D-aspartate-induced death compared to PERK-A neuronal cultures, indicating impaired acquired stress tolerance. Additionally, neuron-astrocyte coculture experiments revealed that the observed difference in acquired stress tolerance was dependent on the astrocyte genotype. The association of PERK-B with transient changes in stress response and reduced stress tolerance with higher vulnerability to cellular stress, albeit transient and small/moderate in size, has clinical relevance based on its potential contribution to the overall genetic vulnerability in neurodegenerative diseases.